Gentherm (THRM) Earnings Expected to Grow: Should You Buy?
Gentherm (THRM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
THRM - Gentherm Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$36.67
DETAILS
HIGH:
$38.00
LOW:
$34.00
MEDIAN:
$38.00
CONSENSUS:
$36.67
UPSIDE:
2.60%
Stock News
Are Investors Undervaluing Gentherm (THRM) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Gentherm Announces Date for 2026 Second Quarter News Release and Conference Call
NOVI, Mich., July 07, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the second quarter 2026 on Thursday, July 23, 2026, and will host a conference call to discuss those results at 8 am (ET) that same day.
Should Value Investors Buy Gentherm (THRM) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Therma Bright Announces Expanded U.S. Orders for Venowave and Mobilizes Supply Chain for Upcoming Sales Volume
The Company Announces Shares for Debt Settlements Toronto, Ontario--(Newsfile Corp. - June 23, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced medical device technologies, is pleased to announce continued sales momentum for its Venowave mobile compression device in the United States, highlighted by additional follow-on orders from Horizon Health USA ("Horizon") and from Gen-X Med. Building on the rapid deployment of previous shipments, Horizon Health USA has placed a new order for 100 Venowave units.
Gentherm Offers Too Much Upside To Be Underperforming Like This
Gentherm Incorporated remains a soft Buy as its transformation and merger with Modine Performance Technologies drive significant upside potential. THRM delivered impressive Q1 FY2026 results: sales up 11.2% to $393.7M, outpacing a contracting vehicle production market. Management guides for FY2026 revenue of $1.5–$1.6B and EBITDA of $175–$195M, with the Modine merger expected to boost combined revenue to $2.6B and EBITDA to $322M.
Modine's $4B AI Coup Freezes Out the Competition
The market consistently misprices the physical infrastructure required to sustain exponential technological growth. Right now, the structural bottleneck for artificial intelligence (AI) is not silicon availability.
Live: Can Modine Manufacturing Rip Higher After Reporting Q4 Earnings Tonight?
Live Updates The analyst who called NVIDIA in 2010 just named his top 10 AI stocksThis analyst's 2025 picks are up 106% on average. He just named his top 10 stocks to buy in 2026. Get them here FREE. Modine Recently Landed Massive $4 Billion Data Center Cooling Agreement 6 minutes ago Live Modine Manufacturing... Live: Can Modine Manufacturing Rip Higher After Reporting Q4 Earnings Tonight?
Gentherm Named a 2025 Supplier of the Year by General Motors
NOVI, Mich., May 26, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM) a global market leader of innovative thermal management and pneumatic comfort technologies, has been presented with a 2025 Supplier of the Year Award at General Motors' 34th annual Supplier of the Year event in Austin, Texas.
Gentherm Announces Participation in Upcoming Second Quarter 2026 Investor Conference
NOVI, Mich., May 20, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that it is scheduled to participate in the following upcoming investor conference in the second quarter of 2026.
Gentherm to Showcase Science-Backed Wellness Experiences Applied to Home and Office at NeoCon 2026
NOVI, Mich., May 14, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced it will showcase its latest expansion into the Home and Office market at NeoCon 2026 in Chicago, IL including Preview Day on June 7, 2026 and exhibit days June 8–10, 2026.
Tech and Semiconductors Lead As Order Flows Expand Across Sectors
Source: TradePulse
Gentherm Incorporated (THRM) Q1 2026 Earnings Call Transcript
Gentherm Incorporated (THRM) Q1 2026 Earnings Call Transcript
Gentherm (THRM) Beats Q1 Earnings and Revenue Estimates
Gentherm (THRM) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.51 per share a year ago.
How Will the Gentherm Deal Enhance Modine's Growth Prospects?
MOD sharpens its focus on the Climate Solutions segment with a $1B Gentherm deal, boosting flexibility, margins and exposure to high-growth thermal markets.
Gentherm (THRM) Earnings Expected to Grow: Should You Buy?
Gentherm (THRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JPMorgan Chase & Co. Lowers Stake in Gentherm Inc $THRM
JPMorgan Chase and Co. reduced its stake in shares of Gentherm Inc (NASDAQ: THRM) by 41.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 63,806 shares of the auto parts company's stock after selling 44,445 shares during the quarter. JPMorgan Chase and
Gentherm Inc (NASDAQ:THRM) Receives $39.40 Consensus Price Target from Analysts
Gentherm Inc (NASDAQ: THRM - Get Free Report) has earned a consensus rating of "Hold" from the seven brokerages that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation and two have assigned a buy recommendation to the company. The average 1
Gentherm Inc $THRM Shares Acquired by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC lifted its position in shares of Gentherm Inc (NASDAQ: THRM) by 6.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 303,557 shares of the auto parts company's stock after acquiring an additional
SG Americas Securities LLC Has $2.04 Million Stock Position in Gentherm Inc $THRM
SG Americas Securities LLC boosted its holdings in Gentherm Inc (NASDAQ: THRM) by 50.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 56,071 shares of the auto parts company's stock after purchasing an additional 18,718 shares during the quarter.
Price Targets
Gentherm price target raised to $38 from $37 at Stifel
$38.00
(was $30.20)
Nathan Jones
·
Stifel Nicolaus
Gentherm price target raised to $34 from $33 at Baird
$34.00
(was $29.61)
Robert W. Baird
Gentherm price target lowered to $37 from $41 at Stifel
$37.00
(was $29.42)
Stifel Nicolaus
Freedom Capital Markets Downgrades Gentherm Incorporated (THRM) to Hold
$38.00
(was $33.25)
Dmitriy Pozdnyakov
·
Loop Capital Markets
Gentherm initiated with a Buy at Stifel
$41.00
(was $32.51)
Stifel Nicolaus
Gentherm price target lowered to $36 from $42 at Baird
$36.00
(was $31.31)
Robert W. Baird
Gentherm price target raised to $53 from $52 at Seaport Research
$53.00
(was $37.30)
Seaport Global
Gentherm price target raised to $42 from $40 at Baird
$42.00
(was $37.16)
Robert W. Baird
Gentherm price target raised to $44 from $42 at Roth Capital
$44.00
(was $37.14)
Roth Capital
Gentherm price target lowered to $60 from $65 at Baird
$60.00
(was $50.96)
Luke Junk
·
Robert W. Baird